McKesson, CD&R Near $5B Takeover of Option Care Health
OPCH sits 58% above its 52-week low of $18.01.
Summary
McKesson and Clayton Dubilier & Rice are in advanced talks to acquire Option Care Health in a deal valuing the company at more than $5 billion including debt. CD&R would take a 51% controlling stake, with McKesson holding 49% and an option to buy CD&R's stake later. Shares jumped 22% in after-hours trading following the report. An agreement could be reached as soon as Tuesday, though negotiations are ongoing. This would be a major strategic move for McKesson into home infusion services and a significant premium for Option Care shareholders.
At the time of this announcement, OPCH was trading at $28.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $18.01 to $36.80. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.